E
Enterin
0 followers
Enterin is the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease
Org chart
Denise Barbut
Co-Founder, Chief Medical Officer & Board Member
Michael Zasloff
Co-Founder, Chief Scientific Officer & Board Member
William Kinney
Co-Founder & SVP of R&D
Richard S. Larson
Chief Medical Officer
Kimberly Man
Vice President Operations
D. Phillip Cox
VP Commercial Manufacturing
Constantine Ward
Global Head of Clinical Trial Supply
Christina Gallagher
Clinical Trials Logistics Manager
Hilde Williams
Senior Regulatory Advisor, Regulatory Strategy & Operations
Joseph Costa
Financial Controller
Board & advisors
Jay Brammer
Chairman
Mark Finn
Board Member
Richard D. Propper
Board Member
Roger Mills
Board Member
Don Munoz
Board Member
Chris Dobson
Scientific Advisor
Michael Camilleri
Scientific Advisor
Linda Greensmith
Scientific Advisor
Wolfgang Kunze
Scientific Advisor
Alexander Fleming
Scientific Advisor
Robert A. Hauser
Scientific Advisory Board Member
Patrik Brundin
Scientific Advisory Board Member
Alan Moses
Scientific Advisory Board Member
Michael Zemel
Scientific Advisory Board Member
K Ray Chaudhuri
Advisor
Tom Laughren
Advisor
Anthony Schapira
Advisor
Rajeev Kumar
Advisor
Elizabeth Cho-Fertikh
Advisor
Thyagarajan Subramanian
Advisor
Barry Miller
Board Member